Status:
ACTIVE_NOT_RECRUITING
Risk Factors and Outcomes of Ischemic Stroke Associated With Tandem or Isolated Cervical Artery Occlusion in Anterior and Posterior Circulation
Lead Sponsor:
Azienda Unità Sanitaria Locale della Romagna
Collaborating Sponsors:
Hospital Universitari Vall d'Hebron Research Institute
Boston Medical Center
Conditions:
Acute Ischemic Stroke Related to Tandem Occlusion
Acute Ischemic Stroke Due to Isolated Cervical Artery Occlusion
Eligibility:
All Genders
Brief Summary
CERES-TANDEM is a multicenter study designed to improve the understanding of "tandem" ischemic stroke -those caused by two blockages in series, one in a neck artery and one in a brain artery-. Because...
Detailed Description
BACKGROUND: Tandem occlusion stroke, defined by concurrent extracranial and intracranial vessel occlusions, remains an underinvestigated subset of acute ischemic stroke. There is a critical gap in kn...
Eligibility Criteria
Inclusion
- acute ischemic stroke
- tandem or isolated cervical artery occlusion (exploratory group)
- emergent extracranial vessel stenting or no stenting (treatment grouping variable)
Exclusion
- hemorrhagic stroke
- no tandem occlusion and no isolated extracranial cervical vessel occlusion
Key Trial Info
Start Date :
January 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2026
Estimated Enrollment :
2880 Patients enrolled
Trial Details
Trial ID
NCT06965036
Start Date
January 1 2018
End Date
October 1 2026
Last Update
October 14 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Boston Medical Center
Boston, Massachusetts, United States, 02118
2
Bufalini Hospital Comprehensive Stroke Center
Cesena, Italy, 47521
3
Vall d'Hebron Institut de Recerca
Barcelona, Spain